Author: Scott Welch
The Biden administration’s first major step toward imposing limits on the pharmacy benefit managers who act as the drug industry’s price negotiators is backfiring, pharmacists say. Instead, it’s adding to the woes of the independent drugstores it was partly designed to help. The so-called PBMs have long clawed back a fee from pharmacies weeks or ...
Employers will be facing a changing landscape when it comes to health care in 2024, as they continue to see significant spending in the areas of mental health, prescription drugs and cancer treatment, says a new survey.
The House of Representatives passed a “two-step” spending bill last week that, along with delaying a government shutdown, bumps back pay cuts for hospitals and extends community health center and training programs.
The technology could reduce clinicians’ administrative work or speed drug discovery, but the rapidly evolving field may need more human oversight to prevent harm, lawmakers and witnesses said.
Kaiser Permanente's healthcare workers voted to ratify a new contract with the hospital chain, the union said on Thursday, ending a months-long negotiation that resulted in the largest recorded strike in the U.S. medical sector.
A new report on how smaller employers have been dealing with rising health care costs revealed that more than 40% are considering switching insurers and more than 25% are looking at increasing deductibles and other out-of-pocket costs for employees.
The e-commerce giant says its Prime customers can now get quick access to a health care provider through a program that costs $9 a month or $99 annually.
Starting Jan. 1, ground ambulance operators will be barred from balance billing, thanks to a new law signed by Democratic Gov. Gavin Newsom. California is the 14th state to provide some protection against balance billing for ground ambulance rides.
The American Medical Association called on insurance companies, employers, and government programs to cover obesity treatments even as many remain reluctant to pay for them, fearing the costs of covering the drugs at a mass scale. The large physicians’ lobbying group voted to pass a resolution at the association’s interim meeting Monday saying it will ...
For the more than 100 million American adults with obesity, medications such as semaglutide (known by its brand names Wegovy and Ozempic) and tirzepatide, a version of which the Food and Drug Administration approved last week, could be transformative. These drugs are remarkably effective in reducing weight, managing diabetes and reducing cardiovascular complications. But there is still much we don’t ...